Sanofi cuts the price of its most prescribed insulin by 78 percent ...Middle East

The Hill - News
Sanofi cuts the price of its most prescribed insulin by 78 percent
French pharmaceutical company Sanofi, one of the top three insulin manufacturers for the U.S., announced on Thursday it would be cutting the list price for its most prescribed insulin product Lantus by 78 percent, joining fellow major insulin manufacturers in drastically minimizing the prices of some of their insulin products. Along with cutting down the price of Lantus, a long acting injection insulin, the company said it would be reducing the cost of its fast-acting insulin product Apidra by 70 percent. Sanofi announced it would also be enacting a $35 cap on out-of-pocket costs for Lantus for patients with commercial insurance coverage as well as capping costs for uninsured patients

Hence then, the article about sanofi cuts the price of its most prescribed insulin by 78 percent was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanofi cuts the price of its most prescribed insulin by 78 percent )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News